Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...

The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication ...

This approval positions Lupin to tap into a substantial market opportunity for a drug indicated for the treatment of ...

Steward Partners Investment Advisory LLC bought a new position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) ...

Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for ...

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Surrounded by family and friends at the kitchen island, Worthington’s Blaise Parrill smiled sheepishly as the familiar words ...

After hours: March 18 at 7:45:54 PM EDT Loading Chart for CPRX ...